Invivyd Inc (IVVD)
1.765
-0.16
(-8.55%)
USD |
NASDAQ |
May 28, 16:00
1.765
0.00 (0.00%)
After-Hours: 18:41
Invivyd Accounts Payable (Quarterly): 1.168M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.168M |
| December 31, 2023 | 7.953M |
| September 30, 2023 | 9.168M |
| June 30, 2023 | 4.112M |
| March 31, 2023 | 5.913M |
| December 31, 2022 | 1.517M |
| September 30, 2022 | 16.77M |
| Date | Value |
|---|---|
| June 30, 2022 | 14.23M |
| March 31, 2022 | 18.68M |
| December 31, 2021 | 5.783M |
| September 30, 2021 | 17.56M |
| June 30, 2021 | 10.72M |
| March 31, 2021 | 11.32M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.168M
Minimum
Mar 2024
18.68M
Maximum
Mar 2022
9.607M
Average
9.168M
Median
Sep 2023
Accounts Payable (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 4.342M |
| Viking Therapeutics Inc | 5.225M |
| Stoke Therapeutics Inc | 2.102M |
| 180 Life Sciences Corp | 1.784M |
| MAIA Biotechnology Inc | 1.872M |